POLIVY® (polatuzumab vedotin-piiq) Clinical Trial Information
Characteristics of Single Pivotal Trials Supporting Regulatory Approvals of Novel Non‐orphan, Non‐oncology Drugs in the European Union and United States from 2012−2016 - Morant - 2019 - Clinical and Translational Science - Wiley Online Library
Participation of the elderly, women, and minorities in pivotal trials supporting 2011–2013 U.S. Food and Drug Administration approvals | Trials | Full Text